La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Oncology Institute Croissance future
Future contrôle des critères 1/6
Oncology Institute is forecast to grow earnings and revenue by 32.3% and 18.9% per annum respectively.
Informations clés
32.3%
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
| Healthcare croissance des bénéfices | 19.4% |
| Taux de croissance des recettes | 18.9% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 16 May 2024 |
Mises à jour récentes de la croissance future
Recent updates
A Piece Of The Puzzle Missing From The Oncology Institute, Inc.'s (NASDAQ:TOI) 28% Share Price Climb
Jul 19
The Oncology Institute, Inc. (NASDAQ:TOI) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
May 05Not Many Are Piling Into The Oncology Institute, Inc. (NASDAQ:TOI) Stock Yet As It Plummets 28%
Mar 21Is Oncology Institute (NASDAQ:TOI) A Risky Investment?
Mar 05The Oncology Institute, Inc. (NASDAQ:TOI) Stock Rockets 49% But Many Are Still Ignoring The Company
Nov 10The Oncology Institute swings to Q2 GAAP loss per share from year-ago profit
Aug 09Shareholders Shouldn’t Be Too Comfortable With Oncology Institute's (NASDAQ:TOI) Strong Earnings
May 18Companies Like Oncology Institute (NASDAQ:TOI) Are In A Position To Invest In Growth
Mar 16Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2025 | 483 | -35 | -22 | -15 | 1 |
| 12/31/2024 | 415 | -54 | -22 | -19 | 1 |
| 6/30/2024 | 361 | -59 | -48 | -44 | N/A |
| 3/31/2024 | 343 | -60 | -40 | -37 | N/A |
| 12/31/2023 | 324 | -68 | -41 | -36 | N/A |
| 9/30/2023 | 310 | -61 | -52 | -46 | N/A |
| 6/30/2023 | 293 | -50 | -64 | -59 | N/A |
| 3/31/2023 | 274 | -40 | -67 | -60 | N/A |
| 12/31/2022 | 252 | 0 | -67 | -62 | N/A |
| 9/30/2022 | 233 | -1 | -75 | -71 | N/A |
| 6/30/2022 | 221 | -2 | -58 | -53 | N/A |
| 3/31/2022 | 210 | 6 | -54 | -50 | N/A |
| 12/31/2021 | 203 | -11 | -36 | -33 | N/A |
| 9/30/2021 | 200 | -6 | -13 | -10 | N/A |
| 6/30/2021 | 195 | -3 | -12 | -10 | N/A |
| 3/31/2021 | 192 | -5 | -11 | -9 | N/A |
| 12/31/2020 | 188 | -14 | -1 | 1 | N/A |
| 12/31/2019 | 155 | -4 | 2 | 4 | N/A |
| 12/31/2018 | 113 | -2 | 5 | 6 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: TOI is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: TOI is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: TOI is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: TOI's revenue (18.9% per year) is forecast to grow faster than the US market (8.8% per year).
Croissance élevée des revenus: TOI's revenue (18.9% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if TOI's Return on Equity is forecast to be high in 3 years time